Cargando…

Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasms

The potential response of immune checkpoint blockade (ICB) in thymic neuroendocrine neoplasms (T-NEN) is largely unknown and full of great expectations. The expression of immune checkpoint molecules and immune infiltrates greatly determine the response to ICB. However, studies regarding the immune l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Man, Hu, Wanming, Zhang, Yixuan, Zhang, Ning, Chen, Luohai, Lin, Yuan, Wang, Yu, Luo, Yanji, Guo, Yu, Chen, Minhu, Chen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531766/ https://www.ncbi.nlm.nih.gov/pubmed/36203421 http://dx.doi.org/10.3389/fonc.2022.917743

Ejemplares similares

Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm
por: Wang, Yuhong, et al.
Publicado: (2018)

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms
por: Liu, Man, et al.
Publicado: (2023)

Immune Checkpoint Markers in Neuroendocrine Carcinoma of the Digestive System
por: Xing, Jiazhang, et al.
Publicado: (2020)

PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
por: Ferrata, Martina, et al.
Publicado: (2019)

Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors
por: Pan, Shen, et al.
Publicado: (2019)

Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis
por: Zhou, Quanwei, et al.
Publicado: (2020)

Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients
por: Jiang, Shuai, et al.
Publicado: (2022)

Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways
por: Wang, Shuyuan, et al.
Publicado: (2023)

Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system
por: Zhang, Rihong, et al.
Publicado: (2022)

Tumor-Infiltrating CD8+ T Cells Driven by the Immune Checkpoint-Associated Gene IDO1 Are Associated With Cervical Cancer Prognosis
por: Zhang, Shun, et al.
Publicado: (2021)

CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas
por: Liu, Liling, et al.
Publicado: (2021)

Neuroendocrine neoplasm with metastasis to the thyroid: a case report and literature review
por: Zhang, Yu, et al.
Publicado: (2023)

Case Report: Response With Immunotherapy in a Patient With Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gallbladder
por: Liu, Chao, et al.
Publicado: (2021)

Histopathology of gastrointestinal neuroendocrine neoplasms
por: Hirabayashi, Kenichi, et al.
Publicado: (2013)

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
por: Luo, Yanji, et al.
Publicado: (2017)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
por: Li, Xi, et al.
Publicado: (2019)

NTF2 Upregulation in HNSCC: a Predictive Marker and Potential Therapeutic Target Associated With Immune Infiltration
por: Xuan, Guangxu, et al.
Publicado: (2022)

The Landscape of Immune Cells Infiltrating in Prostate Cancer
por: Wu, Zhicong, et al.
Publicado: (2020)

Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies
por: Yu, Yixuan, et al.
Publicado: (2022)

A novel signature constructed by super-enhancer-related genes for the prediction of prognosis in hepatocellular carcinoma and associated with immune infiltration
por: Wei, Xueyan, et al.
Publicado: (2023)

Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia
por: Radpour, Ramin, et al.
Publicado: (2021)

Biliary Neuroendocrine Neoplasms: Clinical Profiles, Management, and Analysis of Prognostic Factors
por: Zheng, Zhibo, et al.
Publicado: (2019)

Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors
por: Zhang, Lin, et al.
Publicado: (2022)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers
por: Wang, Han, et al.
Publicado: (2022)

Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer
por: Shi, Jian-yu, et al.
Publicado: (2021)

The Expression of PD-L1 and B7-H4 in Thymic Epithelial Tumor and Its Relationship With Tumor Immune-Infiltrating Cells
por: Yan, Xiaotian, et al.
Publicado: (2021)

The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors
por: Lou, Xin, et al.
Publicado: (2022)

The gene regulatory molecule GLIS3 in gastric cancer as a prognostic marker and be involved in the immune infiltration mechanism
por: Ding, Yi, et al.
Publicado: (2023)

mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
por: Exner, Samantha, et al.
Publicado: (2021)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
por: Bongiovanni, Alberto, et al.
Publicado: (2021)

Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
por: Zhang, Qi, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
por: Gubbi, Sriram, et al.
Publicado: (2022)

Deciphering Prognostic Value of TTN and Its Correlation With Immune Infiltration in Lung Adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2022)

Immune checkpoints in thymic epithelial tumors: challenges and opportunities
por: Girard, Nicolas
Publicado: (2019)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

Imaging-based adipose biomarkers for predicting clinical outcomes of cancer patients treated with immune checkpoint inhibitors: a systematic review
por: Pei, Xinyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_19c00dm026q8l03vj5km6lmbb1